Vaso (VASO) Stock Price

Vaso Price

OTC·CLOSED
0.25USD-0.0020 (-0.80 %)
Market closed

Over the last 19 years Vaso grew revenue by 9.6% annually, reaching 86.77 M USD. Earnings per share have declined at 2.9% per year over the last 10 years. For Vaso, the net margin of 1.1% is broadly stable versus 0.5% a few years ago. The stock trades about 127% above its 52-week low.

Vaso stock price

Volume
Details

Stock Price

How to Read This Chart

This chart tracks the historical stock price of Vaso over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Vaso stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Vaso's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Vaso Stock Price History
DateVaso Price
8/6/20260.25 USD
8/5/20260.25 USD
8/4/20260.25 USD
8/3/20260.26 USD
7/31/20260.19 USD
7/30/20260.19 USD
7/29/20260.20 USD
7/27/20260.20 USD
7/23/20260.19 USD
7/22/20260.20 USD
7/21/20260.19 USD
7/20/20260.19 USD
7/17/20260.20 USD
7/16/20260.20 USD
7/15/20260.20 USD
7/14/20260.20 USD
7/13/20260.19 USD
7/10/20260.20 USD
7/9/20260.19 USD
7/8/20260.19 USD
7/7/20260.19 USD
7/6/20260.19 USD
7/2/20260.19 USD
7/1/20260.18 USD
6/30/20260.19 USD
6/29/20260.18 USD
6/26/20260.19 USD
6/25/20260.19 USD
6/24/20260.20 USD
6/23/20260.19 USD
6/22/20260.18 USD
6/18/20260.18 USD
6/17/20260.18 USD
6/16/20260.19 USD
6/15/20260.19 USD
6/12/20260.19 USD
6/11/20260.19 USD
6/10/20260.19 USD
6/9/20260.19 USD
6/8/20260.19 USD
6/5/20260.20 USD
6/4/20260.19 USD
6/3/20260.20 USD
6/2/20260.20 USD
6/1/20260.22 USD
5/29/20260.21 USD
5/28/20260.21 USD
5/27/20260.22 USD
5/26/20260.23 USD
5/22/20260.23 USD
5/21/20260.21 USD
5/20/20260.23 USD
5/19/20260.23 USD
5/18/20260.25 USD
5/15/20260.23 USD
5/14/20260.19 USD
5/13/20260.19 USD
5/12/20260.20 USD
5/11/20260.20 USD
5/8/20260.18 USD
5/7/20260.18 USD
5/6/20260.19 USD
5/5/20260.19 USD
5/4/20260.18 USD
5/1/20260.19 USD
4/30/20260.18 USD
4/29/20260.18 USD
4/28/20260.18 USD
4/27/20260.18 USD
4/24/20260.18 USD
4/23/20260.19 USD
4/22/20260.19 USD
4/21/20260.19 USD
4/20/20260.19 USD
4/17/20260.18 USD
4/16/20260.17 USD
4/15/20260.17 USD
4/14/20260.16 USD
4/13/20260.16 USD
4/10/20260.16 USD
4/9/20260.16 USD
4/8/20260.16 USD
4/7/20260.16 USD
4/6/20260.16 USD
4/2/20260.16 USD
4/1/20260.17 USD
3/31/20260.17 USD
3/30/20260.17 USD
3/27/20260.17 USD
3/26/20260.18 USD
3/25/20260.18 USD
3/24/20260.18 USD
3/23/20260.18 USD
3/20/20260.17 USD
3/19/20260.17 USD
3/18/20260.17 USD
3/17/20260.17 USD
3/16/20260.17 USD
3/13/20260.17 USD
3/12/20260.17 USD
3/11/20260.17 USD
3/10/20260.17 USD
3/9/20260.17 USD
3/6/20260.17 USD
3/5/20260.17 USD
3/4/20260.17 USD
3/3/20260.18 USD
3/2/20260.18 USD
2/27/20260.18 USD
2/26/20260.18 USD
2/25/20260.18 USD
2/24/20260.18 USD
2/23/20260.17 USD
2/20/20260.18 USD
2/19/20260.18 USD
2/18/20260.18 USD
2/17/20260.17 USD
2/13/20260.18 USD
2/12/20260.18 USD
2/11/20260.18 USD
2/10/20260.18 USD
2/9/20260.18 USD
2/6/20260.19 USD
2/5/20260.19 USD
2/4/20260.19 USD
2/3/20260.19 USD
2/2/20260.19 USD
1/30/20260.18 USD
1/29/20260.18 USD
1/28/20260.17 USD
1/27/20260.17 USD
1/26/20260.17 USD
1/23/20260.18 USD
1/22/20260.17 USD
1/21/20260.17 USD
1/20/20260.17 USD
1/16/20260.17 USD
1/15/20260.17 USD
1/14/20260.17 USD
1/13/20260.17 USD
1/12/20260.18 USD
1/9/20260.18 USD
1/8/20260.17 USD
1/7/20260.17 USD
1/6/20260.17 USD
1/5/20260.17 USD
1/2/20260.17 USD
12/31/20250.17 USD
12/30/20250.18 USD
12/29/20250.18 USD
12/26/20250.17 USD
12/24/20250.17 USD
12/23/20250.17 USD
12/22/20250.17 USD
12/19/20250.17 USD
12/18/20250.17 USD
12/17/20250.17 USD
12/16/20250.17 USD
12/15/20250.17 USD
12/12/20250.17 USD
12/11/20250.17 USD
12/10/20250.17 USD
12/9/20250.17 USD
12/8/20250.17 USD
12/5/20250.17 USD
12/4/20250.16 USD
12/3/20250.16 USD
12/2/20250.16 USD
12/1/20250.16 USD
11/28/20250.16 USD
11/26/20250.16 USD
11/25/20250.15 USD
11/24/20250.15 USD
11/21/20250.14 USD
11/20/20250.14 USD
11/19/20250.17 USD
11/18/20250.14 USD
11/17/20250.14 USD
11/14/20250.12 USD
11/13/20250.11 USD
11/12/20250.11 USD
11/11/20250.11 USD
11/10/20250.11 USD
11/7/20250.11 USD
11/6/20250.12 USD
11/5/20250.12 USD
11/4/20250.12 USD
11/3/20250.11 USD
10/31/20250.11 USD
10/30/20250.11 USD
10/29/20250.11 USD
10/28/20250.11 USD
10/27/20250.11 USD
10/24/20250.12 USD
10/23/20250.11 USD
10/22/20250.11 USD
10/21/20250.12 USD
10/20/20250.12 USD
10/17/20250.12 USD
10/16/20250.12 USD
10/15/20250.12 USD
10/14/20250.12 USD
10/13/20250.12 USD
10/10/20250.12 USD
10/9/20250.12 USD
10/8/20250.12 USD
10/7/20250.12 USD
10/6/20250.12 USD
10/3/20250.12 USD
10/2/20250.12 USD
10/1/20250.12 USD
9/30/20250.12 USD
9/29/20250.12 USD
9/26/20250.12 USD
9/25/20250.12 USD
9/24/20250.11 USD
9/23/20250.12 USD
9/22/20250.12 USD
9/19/20250.12 USD
9/18/20250.12 USD
9/17/20250.12 USD
9/16/20250.12 USD
9/15/20250.13 USD
9/12/20250.12 USD
9/11/20250.12 USD
9/10/20250.12 USD
9/9/20250.12 USD
9/8/20250.13 USD
9/5/20250.12 USD
9/4/20250.13 USD
9/3/20250.13 USD
9/2/20250.13 USD
8/29/20250.13 USD
8/28/20250.12 USD
8/27/20250.13 USD
8/26/20250.12 USD
8/25/20250.12 USD
8/22/20250.12 USD
8/21/20250.12 USD
8/20/20250.11 USD
8/19/20250.12 USD
8/18/20250.13 USD
8/15/20250.13 USD
8/14/20250.12 USD
8/13/20250.12 USD
8/12/20250.13 USD
8/11/20250.12 USD
Access this data via the Eulerpool API

Vaso Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2017
72.79 M USD
-3.83 M USD
-4.54 M USD
Jan 1, 2018
73.98 M USD
-3.72 M USD
-3.73 M USD
Jan 1, 2019
75.52 M USD
590,000.00 USD
-380,000.00 USD
Jan 1, 2020
69.85 M USD
770,000.00 USD
360,000.00 USD
Jan 1, 2021
75.58 M USD
2.82 M USD
6.10 M USD
Jan 1, 2022
80.02 M USD
7.03 M USD
11.87 M USD
Jan 1, 2023
81.02 M USD
4.20 M USD
4.81 M USD
Jan 1, 2024
86.77 M USD
2.22 M USD
951,000.00 USD

Vaso Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 8, 2026, 10:34 PM
 
REVENUEM USD
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM USD
EBITM USD
EBIT MARGIN%
NET INCOMEM USD
NET INCOME GROWTH%
SHARESM
2009201020112012201320142015201620172018201920202021202220232024
4.004.0016.0029.0032.0034.0057.0072.0072.0073.0075.0069.0075.0080.0081.0086.00
-20.00300.0081.2510.346.2567.6526.321.392.74-8.008.706.671.256.17
25.0050.0062.5068.9768.7573.5361.4056.9455.5656.1656.0055.0757.3360.0061.7360.47
1.002.0010.0020.0022.0025.0035.0041.0040.0041.0042.0038.0043.0048.0050.0052.00
-1.00-1.00-3.00-3.00-1.001.003.001.00-3.00-3.002.007.004.002.00
-25.00-25.00-18.75-10.34-3.132.945.261.39-4.17-4.112.678.754.942.33
-1.00-1.00-4.00-3.00-1.001.003.00-4.00-3.006.0011.004.00
300.00-25.00-66.67-200.00200.00-25.0083.33-63.64
99.56101.78111.98158.37159.38156.03157.19159.40162.21165.42167.84170.85173.77174.66175.54175.59
Details

Income Statement Key Figures

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Vaso generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Vaso retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Vaso's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Vaso has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Vaso's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Vaso stock margins

The Vaso margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Vaso. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Vaso.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2017
55.96 %
-5.26 %
-6.24 %
Jan 1, 2018
55.58 %
-5.03 %
-5.04 %
Jan 1, 2019
56.18 %
0.78 %
-0.50 %
Jan 1, 2020
55.22 %
1.10 %
0.52 %
Jan 1, 2021
57.07 %
3.73 %
8.07 %
Jan 1, 2022
60.58 %
8.79 %
14.83 %
Jan 1, 2023
62.44 %
5.18 %
5.93 %
Jan 1, 2024
59.99 %
2.55 %
1.10 %

Vaso Stock Revenue, EBIT, Earnings per Share

The Vaso earnings per share therefore indicates how much revenue Vaso has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2017
0.45 USD
-0.02 USD
-0.03 USD
Jan 1, 2018
0.45 USD
-0.02 USD
-0.02 USD
Jan 1, 2019
0.45 USD
0.00 USD
-0.00 USD
Jan 1, 2020
0.41 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.43 USD
0.02 USD
0.04 USD
Jan 1, 2022
0.46 USD
0.04 USD
0.07 USD
Jan 1, 2023
0.46 USD
0.02 USD
0.03 USD
Jan 1, 2024
0.49 USD
0.01 USD
0.01 USD

Vaso business model & stock analysis

Vaso Corp is a US-American company that was founded in 1987 and is headquartered in New York. The company is publicly traded and specializes in various areas of the healthcare industry. It operates in three segments: medical devices, clinics and clinic providers, and software and services.

Vaso SWOT Analysis

Strengths

Vaso Corp has several key strengths that contribute to its success:

  • Strong market position: Vaso Corp holds a significant market share in the healthcare industry, ensuring its brand recognition and stability.
  • Diverse product portfolio: The company offers a wide range of innovative medical devices and equipment, catering to various medical specialties.
  • Established distribution network: Vaso Corp has an extensive distribution network, enabling efficient delivery of products to healthcare facilities worldwide.
  • Financial stability: The company has maintained solid financial performance, with consistent revenue growth and profitability.

Weaknesses

Despite its strengths, Vaso Corp also faces certain weaknesses:

  • Limited geographic presence: The company's operations are primarily concentrated in specific regions, which limits its ability to fully tap into global markets.
  • Dependence on key clients: Vaso Corp heavily relies on a few major clients for a significant portion of its revenue, making it vulnerable to fluctuations in their demand or financial stability.
  • Technological dependence: The industry is rapidly evolving, and Vaso Corp must continuously invest in research and development to stay ahead, which poses financial and resource challenges.

Opportunities

Vaso Corp can capitalize on the following opportunities:

  • Emerging markets: Expansion into developing healthcare markets presents potential for Vaso Corp to reach new customer segments and increase market share.
  • Advancements in healthcare technology: The growing demand for innovative medical devices provides an opportunity for Vaso Corp to introduce new products and gain a competitive edge.
  • Strategic partnerships: Collaborating with other healthcare companies or institutions can enable Vaso Corp to access new markets, technologies, and expertise.

Threats

Vaso Corp should be mindful of the following threats:

  • Intense competition: The healthcare industry is highly competitive, with numerous established players and new entrants, potentially impacting Vaso Corp's market share and margins.
  • Regulatory challenges: Compliance with stringent healthcare regulations imposes additional costs and may require modifications to products, impacting Vaso Corp's profitability.
  • Economic downturns: During economic crises or recessions, healthcare spending may decrease, affecting demand for Vaso Corp's products and services.

Vaso Segments

Vaso Revenue by Segment (1/6)

  • 3 Years

  • 5 Years

  • Max

Revenue Recognized at a Point in Time
Commissions
Network Services
Revenue Recognized Over Time
Software Sales and Support
Medical Equipment Sales
Medical Equipment Service
Details
Date
Revenue Recognized at a Point in Time
Commissions
Network Services
Revenue Recognized Over Time
Software Sales and Support
Medical Equipment Sales
Medical Equipment Service
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
40.25 M USD
0.00 USD
3.97 M USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
40.19 M USD
0.00 USD
5.54 M USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
29.44 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
129,000.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
49.65 M USD
41.34 M USD
38.36 M USD
37.12 M USD
4.60 M USD
2.36 M USD
123,000.00 USD

Vaso Revenue by Segment (2/6)

  • Max

Managed IT systems and services
Professional sales services
Equipment sales and services
Details
Date
Managed IT systems and services
Professional sales services
Equipment sales and services
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
40.37 M USD
37.82 M USD
2.83 M USD
Jan 1, 2024
42.95 M USD
41.34 M USD
2.48 M USD

Vaso Revenue by Segment (3/6)

  • Max

Revenue Recognized at a Point in Time
Commissions
Network Services
Revenue Recognized Over Time
Software Sales and Support
Medical Equipment Sales
Medical Equipment Service
Details
Date
Revenue Recognized at a Point in Time
Commissions
Network Services
Revenue Recognized Over Time
Software Sales and Support
Medical Equipment Sales
Medical Equipment Service
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
43.20 M USD
37.82 M USD
35.67 M USD
37.82 M USD
4.70 M USD
2.71 M USD
125,000.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD

Vaso Revenue by Segment (4/6)

  • 3 Years

  • 5 Years

  • Max

IT Segment
Managed IT Systems and Services
Professional Sales Services
Professional Sales Services Segment
Professional Sales Service Segment
Equipment Sales and Services
Equipment segment
Equipment
Details
Date
IT Segment
Managed IT Systems and Services
Professional Sales Services
Professional Sales Services Segment
Professional Sales Service Segment
Equipment Sales and Services
Equipment segment
Equipment
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2018
0.00 USD
44.23 M USD
25.51 M USD
0.00 USD
25.51 M USD
4.24 M USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
45.74 M USD
26.21 M USD
0.00 USD
0.00 USD
3.80 M USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
42.92 M USD
29.44 M USD
0.00 USD
0.00 USD
3.22 M USD
0.00 USD
0.00 USD
Jan 1, 2023
40.37 M USD
0.00 USD
0.00 USD
37.82 M USD
0.00 USD
0.00 USD
2.83 M USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD
41.34 M USD
0.00 USD
0.00 USD
0.00 USD
0.00 USD
2.48 M USD

Vaso Revenue by Segment (5/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

IT Segment
Professional Sales Service Segments
Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements
Equipment Segments
Details
Date
IT Segment
Professional Sales Service Segments
Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements
Equipment Segments
Jan 1, 2014
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2015
0.00 USD
0.00 USD
4.35 M USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
0.00 USD
0.00 USD
Jan 1, 2024
42.95 M USD
41.34 M USD
0.00 USD
2.48 M USD

Vaso Revenue by Segment (6/6)

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements
Refers to component of an entity for which there is an accounting requirement to report separate financial information for this particular segment on that component in the entity's financial statements
Details
Date
Component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements
Refers to component of an entity for which there is an accounting requirement to report separate financial information for this particular segment on that component in the entity's financial statements
Jan 1, 2014
4.67 M USD
48,000.00 USD
Jan 1, 2015
31.58 M USD
0.00 USD
Jan 1, 2018
0.00 USD
0.00 USD
Jan 1, 2019
0.00 USD
0.00 USD
Jan 1, 2021
0.00 USD
0.00 USD
Jan 1, 2023
0.00 USD
0.00 USD
Jan 1, 2024
0.00 USD
0.00 USD

Vaso Revenue by Region

  • 3 Years

  • 5 Years

  • 10 Years

  • Max

Domestic United States
Refers to other than United States Countries
Non-domestic foreign
Details
Date
Domestic United States
Refers to other than United States Countries
Non-domestic foreign
Jan 1, 2014
32.91 M USD
2.05 M USD
0.00 USD
Jan 1, 2015
53.86 M USD
3.22 M USD
0.00 USD
Jan 1, 2023
78.84 M USD
0.00 USD
2.18 M USD
Jan 1, 2024
84.70 M USD
0.00 USD
2.07 M USD

Vaso Eulerpool Fair Value

Details

Fair Value Estimate

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Vaso historical P/E ratio, EBIT multiple, and P/S ratio

Vaso annual returns

Details

Annual Return

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Vaso shares outstanding

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2017
162.21 M Stocks
Jan 1, 2018
165.42 M Stocks
Jan 1, 2019
167.84 M Stocks
Jan 1, 2020
170.85 M Stocks
Jan 1, 2021
173.77 M Stocks
Jan 1, 2022
174.66 M Stocks
Jan 1, 2023
175.54 M Stocks
Jan 1, 2024
175.59 M Stocks

Vaso stock splits

In Vaso's history, there have been no stock splits.
Price targets and forecasts for Vaso are not yet available.

Vaso shareholder structure

% Name
31.74272%
Simon Srybnik UEO
Simon Srybnik UEO
5.97865%
Ma (Jun)
Ma (Jun)
1.77967%
Castle (Peter C)
Castle (Peter C)
0.92543%
Rios (Edgar G)
Rios (Edgar G)
0.91409%
Moen (Janey)
Moen (Janey)
0.91074%
Lieberman (David H)
Lieberman (David H)

Vaso Executives and Management Board

9 members · avg. age 65 · 11 % women

JM

Dr. Jun Ma (61)

President, Chief Executive Officer, Director · since 2007

756,635.00 USD

Management

JM

Ms. Jane Moen (45)

Chief Operating Officer, Director, President of VasoHealthcare · since 2018

711,379.00 USD
JN

Mr. Jonathan Newton (63)

Chief Financial Officer, Treasurer, Company Secretary

368,780.00 USD
PC

Mr. Peter Castle (56)

President of the VasoTechnology, Inc. · since 2010

362,000.00 USD

Board of Directors

JM

Mr. Joshua Markowitz (69)

Independent Chairman of the Board

180,000.00 USD
ER

Mr. Edgar Rios (72)

Independent Vice Chairman of the Board

85,000.00 USD
BM

Mr. Behnam Movaseghi (71)

Independent Director

85,000.00 USD
DL

Mr. David Lieberman (80)

Director

70,000.00 USD
LD

Mr. Leon Dembo (70)

Independent Director

70,000.00 USD

Frequently asked questions about Vaso

Vaso Corp's business model focuses on providing healthcare solutions and products. As a leading provider of healthcare information technology, Vaso Corp specializes in offering software and services that enhance patient care delivery and optimize clinical outcomes. The company operates through two primary segments: IT solutions and professional services, including equipment sales. Vaso Corp combines innovative technology with their expertise in the healthcare industry to offer comprehensive solutions that improve patient care and streamline healthcare operations. With a mission to empower healthcare organizations, Vaso Corp is dedicated to driving positive change in the healthcare industry through their cutting-edge solutions and services.

Vaso Corp is primarily active in the healthcare industry, specializing in providing medical technology and software solutions. With its focus on healthcare, Vaso Corp offers a wide range of services, including specialized equipment and devices, IT solutions, clinical training, and consulting services for hospitals and medical institutions. Leveraging its expertise in healthcare technology, Vaso Corp aims to improve patient care, enhance clinical outcomes, and optimize operational efficiency for healthcare providers worldwide. With its strong presence in the healthcare sector, Vaso Corp continues to play a vital role in advancing medical technology and improving healthcare delivery.

The main competitors of Vaso Corp in the market include GE Healthcare, Siemens Healthineers, and Philips Healthcare. These industry giants are renowned for their medical imaging and diagnostic solutions, offering similar products and services as Vaso Corp. In a highly competitive market, Vaso Corp aims to differentiate itself by focusing on innovative technologies, efficient delivery, and exceptional customer service. By continually adapting to changing industry trends and customer demands, Vaso Corp strives to maintain its competitive edge.

Vaso Corp is a company with a rich history and background in the medical technology industry. Founded in 1987, Vaso Corp has been a leading provider of healthcare solutions, specializing in offering advanced medical imaging systems and equipment. With a strong focus on innovation, the company has continuously developed and distributed state-of-the-art imaging technologies to hospitals, clinics, and research facilities worldwide. Vaso Corp's commitment to excellence has garnered them a reputation for delivering high-quality, reliable, and cost-effective solutions to healthcare providers. With decades of experience and a passion for improving patient care, Vaso Corp remains at the forefront of the medical technology industry.

Vaso Corp has achieved several significant milestones. The company has successfully established itself as a leading provider of healthcare IT solutions, specializing in the design and implementation of advanced medical imaging technologies. Vaso Corp has expanded its global presence by establishing strategic partnerships and acquiring prominent industry players. The company's commitment to innovation has resulted in the development of cutting-edge medical imaging software, enhancing diagnostic accuracy and improving patient care. Furthermore, Vaso Corp's consistent dedication to customer satisfaction and quality service has earned them a reputable position in the healthcare industry.

Vaso Corp is primarily present in various countries and regions globally. Some of the key markets where Vaso Corp operates include the United States, Europe, Asia Pacific, and Latin America. With a global presence, Vaso Corp strategically serves clients and customers across these regions, leveraging its expertise in the healthcare technology and services industry.

Vaso Corp represents a set of values and corporate philosophy that prioritize excellence, innovation, and customer satisfaction. The company strives to deliver cutting-edge solutions and services in healthcare IT and medical equipment domains. Vaso Corp values integrity and transparency in its operations, fostering strong relationships with clients and partners. With a focus on technological advancement, Vaso Corp continuously seeks to empower healthcare providers and improve patient outcomes through its state-of-the-art solutions. By combining expertise, industry knowledge, and a customer-centric approach, Vaso Corp remains dedicated to delivering value and contributing to the growth and development of the healthcare industry.

Converted at the current exchange rate, the Vaso share trades at 0.22 EUR (0.25 USD).

Vaso Corp is a US-American company that specializes in the development and marketing of medical products and equipment. The company has been focusing on innovative products and state-of-the-art technologies for almost three decades to meet the needs of its customers. The business activities of Vaso Corp can be divided into three main divisions: VasoMedical, VasoTechnology, and VasoHealthcare. Each division focuses on specific products and services that meet the requirements of their respective industries. VasoMedical is the medical device division of Vaso Corp. It offers a wide range of cardiology diagnostic devices and supportive systems. This includes the VasoScan product line with innovative ultrasound Doppler systems, which allow doctors to measure blood flow in the body and detect possible circulatory disorders. VasoTechnology is a division that specializes in IT solutions and services. The product range includes software and hardware solutions as well as infrastructure services. VasoTechnology offers innovative and customized IT solutions that can be used in both the medical and non-medical sectors. VasoHealthcare is the newest division of Vaso Corp. It offers a unique digital health management system that allows doctors and hospitals to optimize the medical care of their patients. Various technologies such as telemedicine, artificial intelligence, or virtual consulting services are used. The system enables seamless information exchange between doctors and patients, thus contributing to the improvement of patient care. In addition to the mentioned divisions, Vaso Corp also offers a variety of products that perfectly meet the customers' requirements. This includes not only the above-mentioned VasoScan products but also pharmaceuticals and medical devices sold in the VasoPharma business unit. The business model of Vaso Corp is based on the notion that innovation and technology play a crucial role in healthcare. The company aims to offer products and services that improve medical care and increase efficiency in the healthcare sector. The company places great emphasis on quality and user-friendliness. Vaso Corp is an innovative company that impresses with its products as well as its services. It is a leading provider of medical devices, IT solutions, and digital health management systems that advance healthcare and improve patient care.

The revenue cannot currently be calculated for Vaso.

The profit cannot currently be calculated for Vaso.

The P/E ratio cannot be calculated for Vaso at the moment.

The P/S cannot be calculated for Vaso currently.

The Eulerpool Quality Score for Vaso is 3/10.

The ISIN of Vaso is US92233F1021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The WKN of Vaso is A2DHFY. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.

The ticker of Vaso is VASO. The ticker symbol is used to trade Vaso shares on the stock exchange.

Vaso paid dividends every year for the past 0 years.

Vaso is assigned to the 'Health' sector.

The dividends of Vaso are distributed in USD.

All fundamentals and in-depth analysis of Vaso

Our stock analysis for Vaso stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Vaso. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.